Enter Details

Comment on stories, receive email newsletters & alerts.

This is your permanent identity for Business Insider Australia
Your email must be valid for account activation
Minimum of 8 standard keyboard characters


Email newsletters but will contain a brief summary of our top stories and news alerts.

Forgotten Password

Enter Details

Back to log in

Tagged With Biotechnology

A startup searching for a drug to treat hearing loss just got an unusual endorsement from a big biotech

A startup cofounded by a 31-year-old just got a step closer to transplanting pig organs into humans

Everything we know about North Korea's bioweapons program

Here's how the CEO of a $50 billion drugmaker sees tech companies 'disrupting' healthcare

Why the CEO of a $50 billion company thinks you should look to Roger Federer for career inspiration

Here's what the 59-year-old CEO of a $50 billion healthcare company does to stay fit

The CEO of a $50 billion company explains why big-time dealmaking has dropped

A startup cofounded by a 30-year-old just got $38 million to revolutionise the way we transplant organs

A startup trying to get the human body to fight cancer just filed for an IPO

AthenaHealth CEO: Here's what everyone gets wrong in the debate over drug prices

Why an investor at Andreessen Horowitz thinks software is the future of healthcare

A biotech startup that aims to rid our bodies of cells related to ageing just got a big investment

A biotech startup is trying to end poaching by flooding the market with fake rhino horns

A startup that wants to take cancer therapy to the next level just landed a $2.5 billion deal

I asked more than 20 healthcare leaders for their best career advice -- here's the one that stuck with me

We asked healthcare leaders for their best career advice -- and what they shared applies beyond their industry

Here's why pharma giant AbbVie coughed up $10 billion to buy a startup you've never heard of

An experimental treatment wants to harness the power of stem cells to treat baldness

Biotech investor: 'None of us were as smart as we thought we were'

3 things Venrock's Bryan Roberts looks for in a new investment